Literature DB >> 4765400

DNA polymerase associated with human hepatitis B antigen.

P M Kaplan, R L Greenman, J L Gerin, R H Purcell, W S Robinson.   

Abstract

DNA polymerase activity was detected in each of eight preparations of concentrated human hepatitis B antigen (HBAg) rich in Dane particles prepared by high-speed centrifugation of antigen-positive human plasma and in none of seven control preparations prepared in the same way from HBAg-negative plasma. The incorporation of (3)H-thymidine-methyl-5'-triphosphate into DNA was dependent on four deoxyribonucleoside triphosphates and MgCl(2). Treatment of the concentrated HBAg preparations with the nonionic detergent Nonidet P-40 (NP40) more than doubled the enzyme activity. Fractionation of the concentrated HBAg preparation in sucrose density gradients after treatment with NP40 revealed that the enzyme activity appeared within the density range of Dane core antigen but at a slightly higher density than the average for core antigen. The only particles observed by electron microscopy in this region of the gradient were typical 28-nm cores, suggesting that the DNA polymerase activity was associated with a subpopulation of cores. No DNA polymerase activity was found in purified 20-nm HBAg particles. The DNA product of the reaction remained associated with the 110S core and was not susceptible to DNase digestion when associated with the core. Inhibition of the reaction by actinomycin D and daunomycin suggested that the reaction was dependent on a DNA template associated with the core.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4765400      PMCID: PMC356728     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis.

Authors:  M E Bayer; B S Blumberg; B Werner
Journal:  Nature       Date:  1968-06-15       Impact factor: 49.962

2.  A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis.

Authors:  B S Blumberg; B J Gerstley; D A Hungerford; W T London; A I Sutnick
Journal:  Ann Intern Med       Date:  1967-05       Impact factor: 25.391

3.  Viral hepatitis. New light on an old disease.

Authors:  S Krugman; J P Giles
Journal:  JAMA       Date:  1970-05-11       Impact factor: 56.272

4.  Virus-like particles in serum of patients with Australia-antigen-associated hepatitis.

Authors:  D S Dane; C H Cameron; M Briggs
Journal:  Lancet       Date:  1970-04-04       Impact factor: 79.321

5.  An antigen detected in the blood during the incubation period of serum hepatitis.

Authors:  A M Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1968-07       Impact factor: 11.205

6.  Biophysical properties of Australia antigen.

Authors:  J L Gerin; R H Purcell; M D Hoggan; P V Holland; R M Chanock
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

7.  Observations on Australia antigen in Japanese.

Authors:  K Okochi; S Murakami
Journal:  Vox Sang       Date:  1968       Impact factor: 2.144

8.  Poxvirus DNA-dependent RNA polymerase.

Authors:  J R Kates; B R McAuslan
Journal:  Proc Natl Acad Sci U S A       Date:  1967-07       Impact factor: 11.205

Review 9.  Actinomycin and nucleic acid function.

Authors:  E Reich; I H Goldberg
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1964

Review 10.  Hepatitis-associated antigen.

Authors:  N R Shulman
Journal:  Am J Med       Date:  1970-11       Impact factor: 4.965

View more
  203 in total

Review 1.  Toward hepatitis B vaccines.

Authors:  A J Zuckerman; C R Howard
Journal:  Bull N Y Acad Med       Date:  1975-04

2.  Nuclear bodies in the hepatic parenchymal cells in acute viral hepatitis.

Authors:  J O Soares; M C de Moura
Journal:  Experientia       Date:  1975-10-15

3.  Determination of the protein composition of the occlusion-derived virus of Autographa californica nucleopolyhedrovirus.

Authors:  S C Braunagel; W K Russell; G Rosas-Acosta; D H Russell; M D Summers
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-06       Impact factor: 11.205

4.  The complete nucleotide sequence of hepatitis B virus, subtype adr (SRADR) and phylogenetic analysis.

Authors:  M Mukaide; T Kumazawa; A Hoshi; R Kawaguchi; K Hikiji
Journal:  Nucleic Acids Res       Date:  1992-11-25       Impact factor: 16.971

5.  Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment.

Authors:  M Yoshiba; K Sekiyama; F Sugata; H Okamoto; K Yamamoto; S Yotsumoto
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

6.  Evidence for limited humoral immunoglobulin M antibody response to hepatitis B core antigen during acute and chronic hepatitis B virus infections.

Authors:  E G Lindenschmidt; C H Granato; K Kätzner; R Laufs
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948

7.  Core antigen and antibody in woodchucks after infection with woodchuck hepatitis virus.

Authors:  A Ponzetto; P J Cote; E C Ford; R H Purcell; J L Gerin
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

8.  Peripheral blood mononuclear cells and regulatory T cells in acute viral hepatitis.

Authors:  V Barnaba; E Tamburrini; V Laghi; R Cauda; M Levrero; G Ruocco; L Ortona; F Balsano
Journal:  Gut       Date:  1985-07       Impact factor: 23.059

9.  Functions of the internal pre-S domain of the large surface protein in hepatitis B virus particle morphogenesis.

Authors:  V Bruss; K Vieluf
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Insertions within the hepatitis B virus capsid protein influence capsid formation and RNA encapsidation.

Authors:  B Beames; R E Lanford
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.